Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 19.42
+0.20 (1.04%)
May 30, 2025, 2:45 PM CST
SHE:002932 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 26.56 | 74.93 | 4,208 | 1,413 | 468.93 | Upgrade
|
| Depreciation & Amortization | 62.98 | 83.4 | 59.08 | 23.63 | 17.24 | Upgrade
|
| Other Amortization | 14.51 | 11.82 | 2.65 | 0.87 | 0.87 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.79 | -0.31 | -0.01 | - | -0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 85.27 | -4.58 | 646.56 | 21.33 | 6.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | -133.7 | -125.14 | -37.88 | -0.67 | -1.31 | Upgrade
|
| Other Operating Activities | 4.68 | 3.29 | 153.33 | 34.62 | 7.33 | Upgrade
|
| Change in Accounts Receivable | 411.72 | 1,256 | -2,325 | -722.32 | -320.05 | Upgrade
|
| Change in Inventory | 84.76 | 342.82 | -473.38 | -166.86 | -78.58 | Upgrade
|
| Change in Accounts Payable | -644.14 | -1,302 | 1,539 | 530.21 | 265.58 | Upgrade
|
| Change in Other Net Operating Assets | - | 79.95 | 370.01 | - | - | Upgrade
|
| Operating Cash Flow | -85.05 | 392.5 | 4,013 | 1,127 | 359.68 | Upgrade
|
| Operating Cash Flow Growth | - | -90.22% | 256.06% | 213.33% | 1499.59% | Upgrade
|
| Capital Expenditures | -184.77 | -109.97 | -313.38 | -103.57 | -28.28 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.78 | 0.15 | - | - | 0.01 | Upgrade
|
| Investment in Securities | 28.04 | -1,290 | -1,958 | -588 | -22.9 | Upgrade
|
| Other Investing Activities | 17.82 | 34.71 | 37.18 | 6.45 | 7.81 | Upgrade
|
| Investing Cash Flow | -138.12 | -1,365 | -2,234 | -685.12 | -43.37 | Upgrade
|
| Short-Term Debt Issued | - | 23.61 | 137.39 | 30 | 141.5 | Upgrade
|
| Long-Term Debt Issued | 3 | - | - | - | - | Upgrade
|
| Total Debt Issued | 3 | 23.61 | 137.39 | 30 | 141.5 | Upgrade
|
| Short-Term Debt Repaid | - | -125 | -53.42 | -141.5 | - | Upgrade
|
| Long-Term Debt Repaid | -23.61 | -20.49 | -4.72 | -2.95 | - | Upgrade
|
| Total Debt Repaid | -23.61 | -145.49 | -58.14 | -144.45 | - | Upgrade
|
| Net Debt Issued (Repaid) | -20.61 | -121.87 | 79.24 | -114.45 | 141.5 | Upgrade
|
| Issuance of Common Stock | - | - | - | 482.71 | 49.39 | Upgrade
|
| Repurchase of Common Stock | - | -0.53 | - | - | - | Upgrade
|
| Common Dividends Paid | -47.39 | -582.48 | -550.64 | -283.39 | -8.44 | Upgrade
|
| Other Financing Activities | -245.17 | 34.83 | 38.6 | -2.6 | 0.47 | Upgrade
|
| Financing Cash Flow | -313.17 | -670.06 | -432.79 | 82.27 | 182.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.51 | 1.26 | 19.47 | -3.2 | -0.64 | Upgrade
|
| Net Cash Flow | -535.83 | -1,641 | 1,365 | 520.96 | 498.6 | Upgrade
|
| Free Cash Flow | -269.81 | 282.52 | 3,699 | 1,023 | 331.4 | Upgrade
|
| Free Cash Flow Growth | - | -92.36% | 261.47% | 208.82% | - | Upgrade
|
| Free Cash Flow Margin | -77.08% | 37.69% | 35.13% | 36.17% | 34.55% | Upgrade
|
| Free Cash Flow Per Share | -1.20 | 1.24 | 16.09 | 4.84 | 1.59 | Upgrade
|
| Cash Income Tax Paid | 4.45 | 268.9 | 1,253 | 219.86 | 87.78 | Upgrade
|
| Levered Free Cash Flow | - | 281.92 | 2,660 | 631.65 | 259.58 | Upgrade
|
| Unlevered Free Cash Flow | - | 288.49 | 2,662 | 632.97 | 259.99 | Upgrade
|
| Change in Net Working Capital | - | -298.24 | 323.83 | 416.54 | 100 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.